Scalable diagnostic imaging platform

This US-based healthcare platform is building a leading consolidation player in diagnostic imaging in Latin America.

The first clinic has already been acquired in Colombia and six additional acquisition files are in active negotiation. The platform focuses on majority acquisitions of profitable, physician-owned clinics, with medical leadership retained locally.

The governance structure has been institutional from day one, with an international board that includes a former Global CEO of a Big-5 audit firm, a former U.S. Under Secretary of Health and senior leaders from publicly traded healthcare companies.

Combining a disciplined buy-and-build strategy with asset-backed capital structures creates immediate operating cash flow, economies of scale and multiple-expansion toward a strategic exit to a larger regional or international party.

Initial focus: Colombia
Planned expansion: Mexico and selected LATAM markets. A scalable diagnostic imaging platform with real assets and proven traction

Business model
The platform follows a structured four-step strategy.

Selective acquisition
Targeted acquisition of profitable diagnostic clinics with:

• Stable revenue base
• Positive EBITDA
• Strong referral relationships
• Optimization potential
• Ability to integrate real estate and equipment

Operational optimization
EBITDA growth via:

• Centralized purchasing
• Workflow optimization and AI-assisted diagnostics.
• Expansion of additional services (MRI, CT, cardiology)
• Improved insurance contracting
• Structured equipment upgrades

Asset-backed capital model
Integration of separate financing vehicles for:

• Medical devices
• Healthcare real estate

This enables:

• Capital efficient growth
• Limited dilution
• Improved risk profile
• Institutional funding discipline

Strategic exit
Intended exit within 3-5 years via sale to:

• International healthcare operators
• Private equity platforms
• Strategic consolidators

Value creation is driven by scale, professionalization and governance.

USPs.

• Highly fragmented market with 5,000+ physician-owned clinics
• Low entry-level multiple (2-5x EBIT)
• Immediately profitable acquisitions
• Underlying value in real estate and equipment
• Disciplined buy-and-build approach
• Institutional governance from inception
• Clear geographical focus

Investment requirement
Current investment round: €1,200,000
Target closing: March 2026

Already committed:

• €450,000 external investors
• €100,000 equity investment from the founding party

Capital expenditure
Equity component for acquisition of three profitable diagnostic clinics, combined with seller financing and asset-backed structures. Remaining allocation available to strategic co-investors.

Desired competencies investor
The company is seeking investors to participate in an institutional healthcare consolidation platform.

Added value can lie in:

• Healthcare buy-and-build
• Private equity / structured finance
• Medical real estate
• Equipment leasing
• Cross-border expansion

Participation possible via:

• Equity
• Structured equity
• Asset-backed debt

Experience and organization
The platform is supported by an internationally experienced board with backgrounds in:

• Global leadership of a top-tier accounting & advisory organization
• Senior U.S. healthcare government positions
• Leadership experience within publicly traded healthcare companies
• International infrastructure and governance experience

The operational team has expertise in:

• Clinic Management
• Post-Merger Integration (PMI)
• Healthcare IT
• Compliance & finance
• Organization development

Strategic development, capital structuring and international expansion are centrally managed.

The platform was founded by a Dutch entrepreneur with international experience in healthcare structuring and institutional capital building.

Other relevant information.
The diagnostic imaging market in Latin America is structurally underdeveloped compared to the US:

• Significant MRI and CT capability gap
• Long waiting times
• Limited access in secondary regions
• Predominantly sub-scale clinics
• Increasing private insurance penetration

Traction

• Profitable radiology clinic including real estate acquired in 2025
• ~20% revenue growth since acquisition
• 3 LOIs signed + 3 in completion phase
• 15+ clinics in active pipeline
• Pipeline represents >$10M potential EBITDA

Impact

• Increasing diagnostic capacity
• Improved access to care
• Reduction of waiting times
• Equipment modernization
• Contribution to SDG 3 (Health & Well-being).